NMPA approves novel globally trialled therapy before US, Japan, Europe
What China’s first approval ahead of major regulators means for biopharma strategy, timelines, and competitive pressure.
By Abdullah Al-Otaibi·· 3 min
Loading the Newsroom
Curating from trusted global sources…